{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T21:10:16Z","timestamp":1738271416912,"version":"3.35.0"},"reference-count":14,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Chemical Toxicology"],"published-print":{"date-parts":[[1998,1]]},"DOI":"10.3109\/01480549809011645","type":"journal-article","created":{"date-parts":[[2008,6,23]],"date-time":"2008-06-23T18:32:58Z","timestamp":1214245978000},"page":"163-179","source":"Crossref","is-referenced-by-count":7,"title":["Preclinical Toxicological Evaluation of Sertraline Hydrochloride"],"prefix":"10.1080","volume":"21","author":[{"given":"Thomas S.","family":"Davies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William M.","family":"Klowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2008,9,27]]},"reference":[{"key":"CIT0001","first-page":"686","volume":"226","author":"Koe B. K.","year":"1983","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0090-9556(25)07667-6","volume":"17","author":"Tremaine L. M.","year":"1989","journal-title":"Drug Metab. Disposition"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4274(82)90113-8"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/0272-0590(88)90285-0"},{"key":"CIT0005","first-page":"6931","volume":"52","author":"Bendele R.","year":"1992","journal-title":"Cancer Res."},{"key":"CIT0006","unstructured":"Physicans' Desk Reference (PDR). Clomipramine. Product Information. Medical Economics Company, Montvale, NJ (1997a); 819"},{"key":"CIT0007","unstructured":"Physicans' Desk Reference (PDR). Fluoxetine. Product Information. Medical Economics Company, Montvale (1997b); 35"},{"key":"CIT0008","unstructured":"Physicans' Desk Reference (PDR). Fluvoxamine. Product Information. Medical Economics Company, Montvale, NJ (1997c); 2723"},{"key":"CIT0009","unstructured":"Physicans' Desk Reference (PDR). Paroxetine. Product Information. Medical Economics Company, Montvale, NJ (1997d); 2681"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1006\/faat.1994.1058"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1177\/019262339602400411"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-67389-4_3"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/81.10.803"},{"key":"CIT0014","first-page":"5","volume":"12","author":"Monro A","year":"1993","journal-title":"Toxicol. Rev."}],"container-title":["Drug and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/01480549809011645","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T20:46:22Z","timestamp":1738269982000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.3109\/01480549809011645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":14,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2008,9,27]]},"published-print":{"date-parts":[[1998,1]]}},"alternative-id":["10.3109\/01480549809011645"],"URL":"https:\/\/doi.org\/10.3109\/01480549809011645","relation":{},"ISSN":["0148-0545","1525-6014"],"issn-type":[{"type":"print","value":"0148-0545"},{"type":"electronic","value":"1525-6014"}],"subject":[],"published":{"date-parts":[[1998,1]]}}}